HIPPA stands for the Health Insurance Portability and Accountability Act and became law in 1996. This law protects your health information that is directly linked to you by your name, address, social security number, insurance identification number, etc. It gave physicians, hospitals, nurses and healthcare practitioners time to comply with the law.
MCA Staff Writers
Presenting Up-to-Date Mesothelioma Topics
Mesothelioma is diagnosed in about 3000 patients in the USA each year. For decades, only academic scientists and clinicians focused on finding effective treatments for mesothelioma. For rare diseases like mesothelioma, the US Food and Drug Administration (FDA) decided to provide incentives to companies that develop products for treatment of rare diseases through a program known as the Orphan Drug Designation program.
Both smoking and asbestos irritate the lungs. Smoking is a well-known trigger for lung cancer. Chronic exposure to smoke (smoking) causes as many as 90% of lung cancers.1
Doctors use information about each case of mesothelioma to help guide the treatment of each patient. Most commonly, doctors look at how far the mesothelioma has spread which is measured in the tumor-node-metastasis (TNM) stage and the type of tumor cell --epithelioid, biphasic, and sarcomatoid. However, even the same type of mesothelioma—epithelioid— can vary in its rate of growth or aggressiveness. Thus, other factors in mesothelioma must affect its aggressiveness.
Many chemotherapy regimens can damage nerves that serve most of the body, called peripheral nerves. This damage, technically called chemotherapy-induced peripheral neurotherapy (CIPN), causes pain in about 60% of chemotherapy- treated patients.1 While it often begins after the later cycles, it can linger for years.
Tumors, including mesothelioma and the deadly skin cancer melanoma, use several methods to hide from the immune system. Since mesothelioma and melanoma tumors have similar characteristics, some melanoma treatments are being tested for their efficacy on mesothelioma tumors. Many tumors express proteins that turn off the T cells that would normally kill them. Blocking that “off signal” or “checkpoint signal” is a very promising type of immunotherapy for cancer. It’s like opening the handcuffs on a person’s immune response so their immune system can kill the cancer cells.
We often discuss the results of clinical trials so let’s discuss clinical trials in more depth: who participates, what’s being tested, how clinical trials change treatment of future mesothelioma patients.
While a cure for mesothelioma does not exist currently, doctors are working tirelessly to gain a greater understanding of genetic cues that can potentially lead to a cure for mesothelioma. Understanding genetic cues, like genomic mutations, can inform doctors of how mesothelioma develops in patients, which could lead to earlier detection of the disease and creation of individualized treatments for improved prognoses for patients.